156 related articles for article (PubMed ID: 8059010)
1. Restraint changes pentobarbital-induced sleeping time in rats: evidence that arousal is modulated by brain corticotropin-releasing hormone and opioid in stress.
Shibasaki T; Imaki T; Hotta M; Ling N; Demura H
Regul Pept; 1994 May; 51(2):141-9. PubMed ID: 8059010
[TBL] [Abstract][Full Text] [Related]
2. Brain corticotropin-releasing hormone increases arousal in stress.
Shibasaki T; Yamauchi N; Hotta M; Imaki T; Oda T; Ling N; Demura H
Brain Res; 1991 Jul; 554(1-2):352-4. PubMed ID: 1933317
[TBL] [Abstract][Full Text] [Related]
3. Beta 1-adrenergic mechanism is involved in stress-induced increase in arousal.
Shibasaki T; Yamada K; Yamauchi N; Imaki T; Hotta M; Demura H
Neurosci Lett; 1994 Oct; 180(2):167-70. PubMed ID: 7700573
[TBL] [Abstract][Full Text] [Related]
4. Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: evidence that an increase in arousal induced by stress is mediated through CRH receptor type 1.
Arai K; Ohata H; Shibasaki T
Neurosci Lett; 1998 Oct; 255(2):103-6. PubMed ID: 9835225
[TBL] [Abstract][Full Text] [Related]
5. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
6. Psychological stress increases arousal through brain corticotropin-releasing hormone without significant increase in adrenocorticotropin and catecholamine secretion.
Shibasaki T; Imaki T; Hotta M; Ling N; Demura H
Brain Res; 1993 Jul; 618(1):71-5. PubMed ID: 8402179
[TBL] [Abstract][Full Text] [Related]
7. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
9. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats.
Spencer RL; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Jul; 246(1):92-101. PubMed ID: 2839673
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation by muscimol and baclofen on antinociception induced by morphine, beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Kim YH; Choi YS; Yoo JS; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):614-9. PubMed ID: 9053732
[TBL] [Abstract][Full Text] [Related]
11. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
[TBL] [Abstract][Full Text] [Related]
12. mu-Opioid peptide modulation of cardiovascular and sympathoadrenal responses to stress.
Marson L; Kiritsy-Roy JA; Van Loon GR
Am J Physiol; 1989 Oct; 257(4 Pt 2):R901-8. PubMed ID: 2552846
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
Xu JY; Tseng LF
Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
[TBL] [Abstract][Full Text] [Related]
14. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
15. Supraspinal administration of opioids with selectivity for mu-, delta- and kappa-opioid receptors produces analgesia in amphibians.
Stevens CW; Rothe KS
Eur J Pharmacol; 1997 Jul; 331(1):15-21. PubMed ID: 9274924
[TBL] [Abstract][Full Text] [Related]
16. Evidence for an involvement of the mu-type of opioid receptor in the modulation of learning.
Aloyo VJ; Romano AG; Harvey JA
Neuroscience; 1993 Jul; 55(2):511-9. PubMed ID: 8397346
[TBL] [Abstract][Full Text] [Related]
17. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y reverses corticotropin-releasing hormone- and psychological stress-caused shortening of sodium pentobarbital-induced sleep in rats.
Yamada K; Shibasaki T; Tsumori C; Imaki T; Hotta M; Wakabayashi I; Demura H
Brain Res; 1996 Jul; 725(2):272-5. PubMed ID: 8836536
[TBL] [Abstract][Full Text] [Related]
19. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H.
Bot G; Chahl LA; Brent PJ; Johnston PA
Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440
[TBL] [Abstract][Full Text] [Related]
20. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
